A recent study published in PLOS Medicine has found that children whose mothers were diagnosed with depression around the time of pregnancy are more likely to require special educational support. Those exposed to antidepressants during pregnancy showed a slight increase in risk, although the research indicates that this may reflect the severity of the mother's depression rather than the medications themselves.
Read More
Expectant mothers often face challenges in deciding whether to continue antidepressant treatment, driven by concerns about potential impacts on fetal brain development. The risks associated with untreated depression can also pose significant threats to both mother and child. Special educational needs encompass conditions where a child requires additional support for learning, communication, or behavior compared to peers.
Previous observational studies raised alarms about the safety of antidepressants during pregnancy, with a 2016 study suggesting a link to autism spectrum disorder. However, subsequent research indicated that maternal depression and genetic factors could be responsible for these associations. A 2018 systematic review and a 2017 sibling comparison study found that the perceived links to neurodevelopmental conditions diminished when maternal mental health was considered.
In their new research, Saraid McIlvride and her team from the University of Glasgow examined both maternal depression and antidepressant use in a large cohort comprising 167,447 children born in Wales between 2009 and 2016. The study tracked health and educational outcomes up to 2022 when children averaged just under 6 years old. Researchers categorized children based on whether their mothers had a recorded depression diagnosis or had been prescribed antidepressants.
Approximately 7.6 percent of children were born to mothers with a depression diagnosis but no antidepressant prescriptions, while 4.2 percent had both a diagnosis and prescriptions. The analysis indicated that both untreated maternal depression and the use of antidepressants during pregnancy were associated with increased rates of special educational needs, which rose from 20 cases per 100 children in the general population to 23.6 for those with untreated depression, and to 26.5 for those whose mothers received antidepressants alongside a depression diagnosis.
While this suggests a potential connection, McIlvride cautioned that the study cannot definitively state that antidepressants cause these issues, as maternal mental health severity may play a significant role. The researchers highlighted the need for further studies focusing on the severity of depression and other variables that could affect child development outcomes.
Independent specialists have reviewed the research, cautioning that while the findings provide relevant information, they do not establish causation between antidepressant use and developmental risks in children. The study adds to the ongoing discussion about the implications of maternal mental health treatment during pregnancy and the need for more comprehensive research in this critical area.